1st Quarter - Termination Amendment — FABIANI & COMPANY for BIOJECT MEDICAL TECHNOLOGIES INC. (2011)

Firm

FABIANI & COMPANY

Client

BIOJECT MEDICAL TECHNOLOGIES INC.

Income

$30,000

Expenses

—

Terminated

Mar 31, 2011

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
1st Quarter - Report	Apr 20, 2011	$30,000	Replaced
1st Quarter - Termination Amendment (this page)	Jul 20, 2011	$30,000	Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Government funding contracts and procurement related to needle free injuctions systems.

Lobbyist	Covered position, as disclosed
ELIZABETH BARROWS	—
MELISSA DUPREE	—

Contacted: Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Defense, Dept of (DOD)

Medical/Disease Research/Clinical Labs MED

Government funding contracts and procurement related to needle free injuctions systems.

Lobbyist	Covered position, as disclosed
ELIZABETH BARROWS	—
MELISSA DUPREE	—

Contacted: Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.